Pharming Group N.V.
PHARUnited States
1 filed reports · 258 financial concepts · 4 earnings calls · 0 media appearances
Filed reports
1 reports · Dec 2025Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Annual · 20-F/ASEC EDGAR | 1 | 814 | Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2025 | 20-F/A | Dec 31, 2025 | Apr 13, 2026 | 814 | Open |
Financial data
258 concepts · 814 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial254 concepts · 766 facts · Dec 2023 to Dec 2025
- Adjustments of prior periods6 · Dec 2023 to Dec 2025
- Cash and cash equivalents6 · Dec 2023 to Dec 2025
- Deferred tax liabilities (IFRS)6 · Dec 2023 to Dec 2025
- (De)recognition of deferred tax assets6 · Dec 2023 to Dec 2025
- Equity6 · Dec 2023 to Dec 2025
- ifrs-full:DeferredTaxAssets6 · Dec 2023 to Dec 2025
- Intangible assets and goodwill (IFRS)6 · Dec 2023 to Dec 2025
- Lease liabilities6 · Dec 2023 to Dec 2025
- Number of shares outstanding6 · Dec 2023 to Dec 2025
- Other reserves (IFRS)6 · Dec 2023 to Dec 2025
- Property plant and equipment6 · Dec 2023 to Dec 2025
- Share based payments6 · Dec 2023 to Dec 2025
- Accrual for production4 · Dec 2024 to Dec 2025
- Accruals for employees4 · Dec 2024 to Dec 2025
- Accruals for rebates and discounts4 · Dec 2024 to Dec 2025
- Accrued interest4 · Dec 2024 to Dec 2025
- Assets (IFRS)4 · Dec 2024 to Dec 2025
- Authorized share capital4 · Dec 2025
- Bonds issued undiscounted cash flows4 · Dec 2024 to Dec 2025
- Contractual capital commitments4 · Dec 2024 to Dec 2025
- Corporate income tax payable4 · Dec 2024 to Dec 2025
- Corporate income tax receivable4 · Dec 2024 to Dec 2025
- Current assets4 · Dec 2024 to Dec 2025
- Current bonds issued and current portion of noncurrent bonds issued4 · Dec 2024 to Dec 2025
Product2 concepts · 36 facts · Dec 2023 to Dec 2025
- Gross profit (IFRS)18 · Dec 2023 to Dec 2025
- Revenue18 · Dec 2023 to Dec 2025
Geography2 concepts · 12 facts · Dec 2023 to Dec 2025
- Gross profit (IFRS)6 · Dec 2023 to Dec 2025
- Revenue6 · Dec 2023 to Dec 2025
Segments
48 factsFigures broken down by business line, region, product or another axis the company reports on.
Products and services2 members · 36 facts
- JOENJA18 · Dec 2023 to Dec 2025
- RUCONEST18 · Dec 2023 to Dec 2025
Statement geographical2 members · 12 facts
- Europe And Rest Of The World6 · Dec 2023 to Dec 2025
- US6 · Dec 2023 to Dec 2025
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
4 calls · Aug 2025 to Jul 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Jul 30, 2026
- FY2026 Q1May 7, 2026
- FY2025 Q3Nov 6, 2025
- FY2025 Q2Aug 1, 2025
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.